BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 22668346)

  • 1. Microarray analysis and biochemical correlations of oxidative stress responsive genes in retinoblastoma.
    Vandhana S; Lakshmi TS; Indra D; Deepa PR; Krishnakumar S
    Curr Eye Res; 2012 Sep; 37(9):830-41. PubMed ID: 22668346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of curcumin on miRNA expression in human Y79 retinoblastoma cells.
    Sreenivasan S; Thirumalai K; Danda R; Krishnakumar S
    Curr Eye Res; 2012 May; 37(5):421-8. PubMed ID: 22510010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global gene deregulations in FASN silenced retinoblastoma cancer cells: molecular and clinico-pathological correlations.
    Sangeetha M; Deepa PR; Rishi P; Khetan V; Krishnakumar S
    J Cell Biochem; 2015 Nov; 116(11):2676-94. PubMed ID: 25958981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress in retinoblastoma: correlations with clinicopathologic features and tumor invasiveness.
    Deepa PR; Nalini V; Mallikarjuna K; Vandhana S; Krishnakumar S
    Curr Eye Res; 2009 Dec; 34(12):1011-8. PubMed ID: 19958119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of genes associated with tumorigenesis of retinoblastoma by microarray analysis.
    Chakraborty S; Khare S; Dorairaj SK; Prabhakaran VC; Prakash DR; Kumar A
    Genomics; 2007 Sep; 90(3):344-53. PubMed ID: 17604597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seed-targeting anti-miR-21 inhibiting malignant progression of retinoblastoma and analysis of their phosphorylation signaling pathways.
    Ding Y; Wu M; Liu J; Wu C; Huang R; Zhu R; Fei J
    Exp Eye Res; 2014 May; 122():1-8. PubMed ID: 24607444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells.
    Dalgard CL; Gonzalez M; deNiro JE; O'Brien JM
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4542-51. PubMed ID: 19443717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinico-pathological correlations of fatty acid synthase expression in retinoblastoma: an Indian cohort study.
    Vandhana S; Deepa PR; Jayanthi U; Biswas J; Krishnakumar S
    Exp Mol Pathol; 2011 Feb; 90(1):29-37. PubMed ID: 21111730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoblastoma protein purification and transduction of retina and retinoblastoma cells using improved alphavirus vectors.
    DiCiommo DP; Duckett A; Burcescu I; Bremner R; Gallie BL
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3320-9. PubMed ID: 15326157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic microRNA 17-92 cluster is regulated by epithelial cell adhesion molecule and could be a potential therapeutic target in retinoblastoma.
    Kandalam MM; Beta M; Maheswari UK; Swaminathan S; Krishnakumar S
    Mol Vis; 2012; 18():2279-87. PubMed ID: 22969266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trichostatin A-induced TGF-beta type II receptor expression in retinoblastoma cell lines.
    Kashiwagi Y; Horie K; Kanno C; Inomata M; Imamura T; Kato M; Yamamoto T; Yamashita H
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):679-85. PubMed ID: 19737884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artesunate exerts specific cytotoxicity in retinoblastoma cells via CD71.
    Zhao F; Wang H; Kunda P; Chen X; Liu QL; Liu T
    Oncol Rep; 2013 Sep; 30(3):1473-82. PubMed ID: 23818062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic instability and proliferation/survival pathways in RB1-deficient malignancies.
    Pappas L; Xu XL; Abramson DH; Jhanwar SC
    Adv Biol Regul; 2017 May; 64():20-32. PubMed ID: 28242412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of YAP suppresses cell proliferation and elevates the sensitivity of chemotherapy in retinoblastoma cells through lipid-peroxidation induced ferroptosis.
    Zhong L; Meng X; Huang J; Hao W; Zuo Y
    Chin Clin Oncol; 2023 Oct; 12(5):52. PubMed ID: 37964544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of lncRNA PVT1 inhibits retinoblastoma progression by sponging miR-488-3p.
    Wu XZ; Cui HP; Lv HJ; Feng L
    Biomed Pharmacother; 2019 Apr; 112():108627. PubMed ID: 30797143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular basis of cancer suppression by the retinoblastoma gene.
    Lee WH
    Princess Takamatsu Symp; 1989; 20():159-70. PubMed ID: 2488231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor suppressor genes and ROS: complex networks of interactions.
    Vurusaner B; Poli G; Basaga H
    Free Radic Biol Med; 2012 Jan; 52(1):7-18. PubMed ID: 22019631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The RB protein family in retinal development and retinoblastoma: new insights from new mouse models.
    Bremner R; Chen D; Pacal M; Livne-Bar I; Agochiya M
    Dev Neurosci; 2004; 26(5-6):417-34. PubMed ID: 15855771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of RB gene mutations in patients with retinoblastoma. Implications for clinical genetic screening.
    Harbour JW
    Ophthalmology; 1998 Aug; 105(8):1442-7. PubMed ID: 9709755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraocular tumor suppression of retinoblastoma gene-reconstituted retinoblastoma cells.
    Madreperla SA; Whittum-Hudson JA; Prendergast RA; Chen PL; Lee WH
    Cancer Res; 1991 Dec; 51(23 Pt 1):6381-4. PubMed ID: 1933901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.